Exelixis Moves Into RNA-Modifying Cancer Therapy With Storm Pact

 
• By Joseph Haas
  
Business partners hands on top of each other symbolizing companionship
Exelixis is building an early-stage cancer pipeline via partnerships

More from Deals

More from Business